SKVI — SKINVISIBLE, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1085277 ·
Last close
$0.20
Market Cap
$1.09M
52W High
$0.90
52W Low
$0.14
ADV30
80
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 5,000 | 5,000 | -125,938 | -267,184 | 119,419 | 1,798 | 10,649,384 |
| Dec 2025 | 5,000 | 5,000 | -114,169 | -258,357 | 127,567 | 2,620 | 10,390,348 |
| Sep 2025 | 5,000 | 5,000 | -106,057 | -250,245 | 133,623 | 645 | 10,138,047 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,512
Investing CF
$-4,086
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.20
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-41,277,360
Inventory
—
Receivables
$22,592
ST Investments
—
EBIT TTM
$-477,871
Pretax Income TTM
$-1,050,213
Interest Exp TTM
$572,342
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$20,000
EBITDA
$-438,742
Free Cash Flow
$275,283
Enterprise Value
$6,945,136
Total Cash
$3,959
Total Debt
$5,862,923
Shares Out
5,403,843
Trailing EPS
$-0.20
Book Value
$-2.00
ROE
—
ROA
-215.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 20,000 | -496,315 | -1,064,034 | 127,567 | 10,390,348 | -10,262,781 | -38,410 |
| Dec 2024 | 20,000 | -589,589 | -565,654 | 158,217 | 9,381,744 | -9,223,527 | -69,834 |
| Dec 2023 | 20,000 | -490,375 | -2,382,440 | 162,869 | 9,185,912 | -9,023,043 | -77,157 |
| Dec 2022 | 279,296 | -238,432 | -1,224,887 | 246,793 | 6,887,396 | -6,640,603 | 45,170 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CDT | CDT Equity Inc. | $1.10M | $0.08 | — |
| EVFM | Evofem Biosciences, Inc. | $1.06M | $0.01 | — |
| CMND | Clearmind Medicine Inc. | $1.19M | $0.80 | — |
| PTIX | Protagenic Therapeutics, Inc.\new | $1.40M | $0.77 | — |
| CPMD | CANNAPHARMARX, INC. | $1.42M | $0.00 | — |
Recent Insider Activity
No insider activity indexed for this ticker.